Evidence map›Paper›PMID 29779198›Full record

ReviewCurrent psychiatry reports2018

Redeveloping Substance Abuse Treatment for Military Personnel.

Christian Schrader, Antoinette Lenton, Peter Gertonson, Alexander Rahimi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christian SchraderPsychiatry Residency, Tripler Army Medical Center, 1 Jarrett White Rd, Honolulu, HI, 96859, USA. christian.c.schrader.mil@mail.mil.
Antoinette LentonPsychiatry Residency, Tripler Army Medical Center, 1 Jarrett White Rd, Honolulu, HI, 96859, USA.
Peter GertonsonPsychiatry Residency, Tripler Army Medical Center, 1 Jarrett White Rd, Honolulu, HI, 96859, USA.
Alexander RahimiPsychiatry Residency, Tripler Army Medical Center, 1 Jarrett White Rd, Honolulu, HI, 96859, USA.
Tripler Army Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewWe review the prevailing evidence surrounding treatment of substance use disorder (SUD), with specific focus on alcohol, tobacco, and prescription opiates, and how it informs guidelines for treating active duty military. We survey the evidence regarding preventive screening, treatment, and relapse prevention in substance misuse as it pertains to patient-centered care of the service member. RECENT

findingsHolistic, patient-centered care with an emphasis on identifying maladaptive use or dependence prior to progression to chronic disease is now recognized as the evidenced approach to treating substance use disorders. Early patient-guided intervention with combined behavioral and pharmacologic therapies leads to better outcomes, including greater functional status, lower relapse rates, and decreased rate of psychiatric and other comorbidities. The military has prioritized a patient-centered approach to screening, assessing, and treating SUD. Recent guideline updates represent a progressive, patient-centered approach in delivering unprecedented access to care, serving as a positive example in treating what is widely accepted as one of the country's most pressing public health concerns.

Indexed as

FemaleHumansMaleMilitary PersonnelPatient-Centered CareSecondary PreventionSubstance-Related DisordersUnited StatesAlcohol treatmentMilitary substance useOpiate use disorderTobacco cessation

Identifiers

PMID29779198
OpenAlexW2804741163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.